Fear can take over the moment prostate cancer progresses. These questions can help caregivers replace confusion with clarity, ...

Infigratinib demonstrated antitumour activity in FGFR2 amplified gastric cancer with a 23.8% response rate and manageable safety profile.

Trodelvy dosing is 10 mg/kg IV on days 1 and 8 of 21-day cycles, continued until progression or unacceptable toxicity; pembrolizumab schedules follow prescriber determination. Safety requires ...

Systemic anti-cancer therapies, including chemotherapy, targeted therapies, immunotherapies, and hormone treatments, are essential components of modern oncology. In patients with metastatic disease, ...

Ageing is an important risk factor for cancer incidence and augments cancer progression. A shared hallmark of ageing and cancer is metabolic reprogramming, which has been suggested to be not only a ...

Dr Ruquaya Ahmad Mir explains why kidney cancer is often detected late. Here is why knowing the early signs is crucial.

A large analysis of two major clinical trials has found that the spread of prostate cancer can be detected on imaging scans even when biomarkers remain stable in patients treated with androgen ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

Uterine cancer is staged using the FIGO and TNM systems based on tumor size, lymph nodes, and metastasis. Stage 1 uterine cancer may involve abnormal vaginal bleeding and is often treated with surgery ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

Metabo-oncology is an emerging interdisciplinary field at the intersection of oncology, metabolism, and obesity research. Epidemiological studies have ...

By Nancy Lapid June 3 (Reuters) - A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide protection against many types of cancer. More than ...